Oral Microbial Shift Following 1-Month Supplementation of Probiotic Chewable Tablets Containing UBLRu-87 as an Adjunct to Phase 1 Periodontal Therapy in Chronic Periodontitis Patients: A Randomized Controlled Clinical Trial.

Context: Although as a probiotic was established as a treatment for a wide range of systemic infections, its role in periodontitis and oral microbiota is still under investigation.

Aims: The present randomized clinical trial was aimed to evaluate the effects of probiotic chewable tablets containing along with initial periodontal therapy on clinical parameters and oral microbiota of chronic periodontitis (CP) patients.

Settings And Design: The randomized controlled clinical trial.